Step 1

Draft

Step 2

Unite with Fellow Investors

Step 3

Choose the Best Attorney

Step 4

Provide Documents

Step 5

Follow Case Progress

Step 6

Get Payout

XLY.TO

id: 876

Auxly (XLY) And FSD Pharma Project Settlement

The settlement funds have been distributed to claimants.

$4,000,000

Cash Settlement

CV-19-00617136-00CP

Case number

11/12/2018

Class period Start

02/06/2019

Class period End

03/28/2024

Claim deadline

Auxly was accused of leaving out important details about a project with FSD Pharma. 
$XLY fell 4% and lost $40.08M of its market cap, damaging investors;
Auxly agreed to pay CAD $4M to investors to resolve the claims.
Auxly was accused of leaving out important details about a project with FSD Pharma to build a large cannabis cultivation space in Ontario from its Q2 2018 report. 

On this news, $XLY fell 4% and lost $40.08M of its market cap, damaging investors.

Initially, Auxly was to get almost half of the cannabis from FSD's Cobourg facility, along with a 220,000-square-foot cultivation space. 

A dispute arose over contract breaches related to FSD's management and staffing obligations, and infrastructure concerns. In 2019, Auxly ended its joint venture with an FSD Pharma subsidiary in Ontario.

Any investor who purchased $XLY between November 2018 and February 2019 may be eligible for a payout.

Case Type

Canadian Securities Class Action

Case Status

Disbursed

Alleged Offence

Mismanagement,

Misleading Statements,

Omissions

Suspected Party

Directors,

Management

Security Type

Stocks

Trade Direction

Long

Payout per Share

0.15

Plaintiffs

Daniel Relvas

Attorneys

Berger Montague (Canada) PC

Judge

Edward Morgan

Settlement agreement date

2023-11-14

Court hearing date

11/14/2023

Objection deadline

10/20/2023

Trades matching type

FIFO

Trusted by industry leaders

Endorsed by top professionals who trust our innovative solutions to drive impactful results.